Swiss Business Hub Italy – presso Consolato di Svizzera a Milano – vi invita il 15 Giugno alle ore 17:00 al webinar “Tomorrow’s health: the future of cancer immunotherapy “
Today, immunotherapy is one of the most exciting areas of new discoveries and treatments for different types of cancer. The new generation of cancer immunotherapies is attracting high-dollar investments from leading venture capital and corporate players. However, competition is fierce with currently hundreds of compounds in development.
Hear from experts from the academia, and the industry about the exciting developments and initiatives in Switzerland and how these aim to improve cancer patient treatment outcomes. The discussion will also shed light on both the scientific hurdles and the organizational challenges that the field is confronted with.
Immediately after the discussion, participants will be invited to join one of three different thematic breakout sessions followed by an interactive Q&A session with the speakers. Just type your questions into the designated chat box and hear them getting answered.
Ana Maria Mendes Cerdeira, Ph.D.
VP, Strategic Planning and Portfolio Strategy of Molecular Partners
Andrea Alimonti, Prof. Dr.
Head, Molecular Oncology, Institute of Oncology Research, Switzerland
Brian Hashemi, Dr.
Managing Partner, Salus Partners SA and Chairman, Novigenix SA
Marija Plodinec, Dr
CEO, Board Member and Co-Founder of ARTIDIS
Lana Kandalaft, Pharma D., Ph.D.
Assistant Professor & Director, Center for Experimental Therapeutics, Department of Oncology, University of Lausanne; Tenure Track Assistant Professor, Ludwig Cancer Research Lausanne Branch